Drug-induced interstitial lung disease

Current Opinion in Pulmonary Medicine

Volumn 2, Issue 5, 1996, Pages 396-404

  Limper, Andrew H ^a   Rosenow III, Edward C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; DRUG;

CAUSE OF DEATH; CHEMICALLY INDUCED DISORDER; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG; MEDIASTINUM; PATHOLOGY; PLEURA; REVIEW;

ANTI-ARRHYTHMIA AGENTS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; CAUSE OF DEATH; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; MEDIASTINUM; PHARMACEUTICAL PREPARATIONS; PLEURA;

EID: 0030225357     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-199609000-00009     Document Type: Article

References (50)

1. Rosenow EC III: Drug-induced pulmonary disease. Dis Month 1994, 40:253-310.
2. Rosenow EC III, Martin WJ II: Drug-induced interstitial lung disease. In Interstitial Lung Disease, edn 2. Edited by Schwarz MI, King TE Jr. St. Louis: MosbyYear Book; 1993:255-270.
3. Cooper JAD Jr, ed: Drug-induced pulmonary disease. Clin Chest Med 1990, 11:1-119.
4. Myers JL: Diagnosis of drug reactions in the lung. Monogr Pathol 1993, 32-53.
5. Rosenow EC III: Drug-induced pulmonary disease. In Textbook of Respiratory Medicine. Edited by Murray JF, Nadel JA. Philadelphia: WB Saunders; 1994:2117-2144.
6. Akoun GM, White JP: Treatment-induced respiratory disorders. In Drug-Induced Disorders, vol 3. Edited by Dukes MNG. Amsterdam: Elsevier; 1989:1-377.
7. Aronchick JM, Gefter WB: Drug-induced pulmonary disorders. Semin Roentgenol 1995, 30:18-34. This extensive review thoroughly examines radiographic and clinical features of drug-induced lung disease and serves as an excellent reference.
8. Cooper JAD Jr, White DA, Matthay RA: Drug-induced pulmonary disease: part 1. Cytotoxic drugs. Am Rev Respir Dis 1986, 133:321-340.
9. Cooper JAD Jr, White DA, Matthay RA: Drug-induced pulmonary disease. Part 2: Noncytotoxic drugs. Am Rev Respir Dis 1986, 133:488-505.
10. Reed CR, Glauser FL: Drug-induced noncardiogenic pulmonary edema. Chest 1991, 100:1120-1124.
11. Taylor CR: Diagnostic imaging techniques in the evaluation of drug-induced pulmonary disease. Clin Chest Med 1990, 11:87-94
12. Padley SP, Adler B, et al.: High-resolution computed tomography of drug-induced lung disease. Clin Radiol 1992, 46:232-236.
13. Patz EF Jr, Peters WP, Goodman PC: Pulmonary drug toxicity following high-dose chemotherapy with autologous bone marrow transplantation: CT findings in 20 cases. J Thorac Imaging 1994, 9:129-134.
14. Moinuddin M: Radionuclide scanning in the detection of drug-induced lung disorders. J Thorac Imaging 1991, 6:62-67.
15. Akoun GM, Cadranel JL, et al.: Bronchoalveolar lavage cell data in drug-induced pneumonitis. Allerg Immunol 1991, 23:245-252.
16. Lehne G, Lote K: Pulmonary toxicity of cytotoxic and immunosuppressive agents: a review. Acta Oncol 1990, 29:113-124.
17. Jules-Elysee K, Stover DE, et al.: Pulmonary complications in lymphoma patients treated with high-dose therapy autologous bone marrow transplantation. Am Rev Respir Dis 1992, 146:485-491.
18. Fauroux B, Meyer-Milsztain A, et al.: Cytotoxic drug-induced pulmonary disease in infants and children. Pediatr Pulmonol 1994, 18:347-355.
19. Cockerill FR III, Wilson WR, et al.: Open lung biopsy in immunocompromised patients. Arch Intern Med 1985, 145:1398-1404.
20. Santrach PJ, Askin FB, et al.: Nodular form of bleomycin-related pulmonary injury in patients with osteogenic sarcoma. Cancer 1989, 64:806-811.
21. Bellamy EA, Husband JE, et al.: Bleomycin-related lung damage: CT evidence. Radiology 1985, 156:155-158.
22. Ingrassia TS, Ryu JH, et al.: Oxygen-exacerbated bleomycin pulmonary toxicity. Mayo Clin Proc 1991, 66:173-178.
23. Van Barneveld RWC, Sleijfer DT, et al.: Natural course of bleomycin-induced pneumonitis: a follow-up study. Am Rev Respir Dis 1987, 135:48-51.
24. Massin F, Fur A, et al.: Busulfan-induced pneumopathy. Rev Mal Respir 1987, 4:3-10.
25. Sheldon R, Slaughter D: A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma. Cancer 1986, 58:1428-1436.
26. O'Driscoll BR, Hasleton PS, et al.: Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood. N Engl J Med 1990, 323:378-382.
27. Andersson BS, Luna MA, et al.: Fatal pulmonary failure complicating high-dose cytosine arabinoside therapy in acute leukemia. Cancer 1990, 65:1079-1084.
28. Martin WJ II, Rosenow EC III: Amiodarone pulmonary toxicity: recognition and pathogenesis, Part I. Chest 1988, 93:1067-1075.
29. Martin WJ II, Rosenow EC III: Amiodarone pulmonary toxicity: recognition and pathogenesis, Part II. Chest 1988, 93:1242-1248.
30. Fraire AE, Guntupalli KK, et al.: Amiodarone pulmonary toxicity: a multi-disciplinary review of current status. South Med J 1993, 86:67-77.
31. Lapinsky SE, Mullen JB, Balter MS: Rapid pulmonary phospholipid accumulation induced by intravenous amiodarone. Can J Cardiol 1993, 9:322-324.
32. Van Mieghem W, Collen L, et al.: Amiodarone and the development of ARDS after lung surgery. Chest 1994, 105:1642-1645.
33. Mickleborough LL, Maruyama H, et al.: Are patients receiving amiodarone at increased risk for cardiac operations? Ann Thorac Surg 1994, 58:622-629.
34. Morrow B, Shorten GD, Sylvester W: Postoperative amiodarone pulmonary toxicity. Anaesth Intensive Care 1993, 21:361-362.
35. Kuhlman JE, Teigen C, et al.: Amiodarone pulmonary toxicity: CT findings in symptomatic patients. Radiology 1990, 177:121-125.
36. Holmberg L, Boman G, et al.: Adverse reactions to nitrofurantoin: analysis of 921 reports. Am J Med 1980, 69:733-738.
37. Holmberg L, Boman G: Pulmonary reactions to nitrofurantoin. 447 cases reported to the Swedish Adverse Drug Reaction Committee 1966-1976. Eur J Respir Dis 1981, 62:180-189.
38. Boyd O, Gibbs AR, Smith AP: Fibrosing alveolitis due to sulphasalazine in a patient with rheumatoid arthritis. Br J Rheumatol 1990, 29:222-224.
39. Sitbon O, Bidel N, et al.: Minocycline pneumonitis and eosinophilia: a report on eight patients. Arch Intern Med 1994, 154:1633-1640.
40. Thisted B, Krantz T, et al.: Acute salicylate self-poisoning in 177 consecutive patients treated in ICU. Acta Anaesth Scand 1987, 31:312-316.
41. Leatherman JW, Schmitz PG: Fever, hyperdynamic shock, and multiple-system organ failure: a pseudo-sepsis syndrome associated with chronic salicylate intoxication. Chest 1991, 100:1391-1396.
42. McKendry RJR, Cyr M: Toxicity of methotrexate compared with azathioprine in the treatment of rheumatoid arthritis: a case-control study of 131 patients. Arch Intern Med 1989, 149:685-689.
43. Hargreaves MR, Mowat AG, Benson MK: Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis: report of five cases and review of published reports. Thorax 1992, 47:628-633.
44. Peces R, Riera JR, et al.: Goodpasture's syndrome in a patient receiving penicillamine and carbimazole. Nephrol 1987, 45:316-320.
45. O'Donnell AE, Selig J, et al.: Pulmonary complications associated with illicit drug use: an update. Chest 1995, 108:460-463. A large retrospective and conconcurrent anaylsis of pulmonary complications occurring in illicit drug users. This useful study provides insight into the changing spectrum of pulmonary disease in these patients.
46. Albertson TE, Walby WF, Derlet RW: Stimulant-induced pulmonary toxicity. Chest 1995, 108:1140-1149. A complete review of pulmonary effects of cocaine and amphetamines. Because of increased illicit use of these agents, this in an outstanding resource for pulmonary practioners.
47. Pare JP, Cote G, Fraser RS: Long-term follow-up of drug abusers with intravenous talcosis. Am Rev Respir Dis 1989, 139:233-241.
48. Allen JN, Davis WB: Eosinophilic lung diseases. Am J Respir Crit Care Med 1994, 150:1423-1438.
49. Biron P, Dessureault J, Napke E: Acute allergic Interstitial pneumonitis Induced by hydrochlorothiazide. Can Med Assoc J 1991, 145:28-34.
50. Fine SR, Lodha A, et al.: Hydrochlorothiazide-induced acute pulmonary edema. Ann Pharmacother 1995, 29:701-703. This clinically useful case report and literature review examines the idiosyncratic development of pulmonary edema after ingestion of hydrochlorothiazide.